Zynerba
-
Devon’s Zynerba Secured in $2 Million Deal by Harmony Biosciences
Devon-based Zynerba is set to be acquired by Harmony Biosciences Holdings in a $2 million deal, writes John George for the Philadelphia Business Journal. …
-
Aclaris Therapeutics in Malvern Files for IPO
Aclaris Therapeutics, a Chester County specialty pharmaceutical company focused on treating skin disorders, is seeking to raise up to $86.25 million in its IPO, and…
-
Update: Zynerba Pharmaceuticals Adds Board Members As Stock Rides Post-IPO Roller Coaster
Zynerba Pharmaceuticals is still experiencing a rollercoaster ride on the NASDAQ under the ticker ZYNE, since launching its more than fully subscribed Initial Public Offering…
















































